Published in Dokl Akad Nauk on January 01, 1997
Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol (2004) 1.08
Glucose-induced effects and joker function of glucose: endocrine or genotoxic prevalence? Horm Metab Res (2006) 0.99
[Morphological characteristics of the formation and reconstruction of bone tissue in the replacement of extensive bone defects]. Ortop Travmatol Protez (1984) 0.98
CYP19 gene polymorphism in endometrial cancer patients. J Cancer Res Clin Oncol (2001) 0.87
Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology (1982) 0.84
[Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer]. Mol Biol (Mosk) (2004) 0.84
[Excretion of cyclic adenosine monophosphate in breast and lung cancer]. Vopr Onkol (1976) 0.82
Aromatase in breast cancer tissue--localization and relationship with reproductive status of patients. J Cancer Res Clin Oncol (1996) 0.81
[Distraction osteosynthesis in occlusive diseases of the limb arteries]. Khirurgiia (Mosk) (1998) 0.80
[A polymorphism study of the CYP19 gene in endometrial cancer patients]. Vopr Onkol (2000) 0.79
[Aromatase (estrogen synthetase) gene expression in human leukocytes]. Ross Fiziol Zh Im I M Sechenova (2000) 0.79
[Age-related changes in adenylate cyclase activity, lipid composition and lipid peroxidation in rat intestinal mucosa: comparison with the frequency of spontaneous tumors]. Vopr Onkol (1985) 0.78
[Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes]. Vestn Ross Akad Med Nauk (2013) 0.78
Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy. Bull Exp Biol Med (2004) 0.78
[Characteristics of dyslipidemia in cancer patients]. Vopr Onkol (1986) 0.77
[The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women]. Vopr Onkol (2012) 0.77
[Effect of phenformin on mammary gland tumor induction in rats]. Vopr Onkol (1974) 0.77
[Polymorphism of glucose intolerance and insulin resistance susceptibility genes in oncological patients]. Mol Biol (Mosk) (2009) 0.77
[Registry-based analysis of cancer and diabetes combination: prevalence and features]. Vopr Onkol (2007) 0.76
[Relation of blood lipids and insulin to body fat content, body surface area and state of the subcutaneous fatty tissue in patients with breast and lung cancer]. Vopr Onkol (1985) 0.76
[Aromatase gene expression and its modifying factors in breast tumor tissue]. Vopr Onkol (1999) 0.76
[Effectiveness of aromatase inhibitors in comparison with metformin for neoadjuvant treatment in patients with endometrial cancer]. Vopr Onkol (2011) 0.76
Induction of the estrogen effect-switching phenomenon by ethanol and its correction. Neurosci Behav Physiol (2002) 0.76
[Cognitive function in patients with endometrial and colorectal cancer: connection with hormonal and metabolic status]. Vopr Onkol (2004) 0.76
[Features of carcinogenesis and aging in knockout male mice PARP-1]. Vopr Onkol (2010) 0.76
[Effect of thyroxine on the hypothalamic concentration of biogenic amines in rats of different ages]. Fiziol Zh SSSR Im I M Sechenova (1978) 0.76
Ability of lymphocytes infiltrating breast-cancer tissue to convert androstenedione. Int J Cancer (1998) 0.76
[Exosomal intercellular communication system and its role in the process of metastatic dissemination]. Vopr Onkol (2014) 0.76
Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects. Exp Oncol (2006) 0.76
Aromatase (CYP19) expression in tumor-infiltrating lymphocytes and blood mononuclears. J Cancer Res Clin Oncol (2002) 0.76
[The excretion of classical estrogens and total phenolsteroids in patients with uterine cancer]. Vopr Onkol (1967) 0.76
[Endometrial cancer, estrogens and metabolic syndrome: scenario becomes more complicated]. Vopr Onkol (2014) 0.76
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin]. Vopr Onkol (1975) 0.75
[Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes]. Vopr Onkol (2012) 0.75
[Anahormone chimeras. Conjugates of melanocyte-stimulating pituitary hormone (MSH) with human melanoma antigens]. Dokl Akad Nauk SSSR (1974) 0.75
[Catechol estrogen excretion in women receiving estrogen replacement therapy]. Biull Eksp Biol Med (1999) 0.75
[Catecholestrogens: synthesis, properties and role in carcinogenesis]. Vopr Onkol (1997) 0.75
[Content of cyclic nucleotides, cholesterol and phospholipids in tumors of the large intestine]. Vopr Onkol (1985) 0.75
[Adrenal steroids in patients with breast cancer and in women with age-related impaired glucose tolerance]. Vopr Onkol (1996) 0.75
[Effect of phenformin on fat-carbohydrate metabolism in pregnant rats]. Biull Eksp Biol Med (1976) 0.75
[Adaptational and thyroid homeostasis and the state of fat and carbohydrate metabolism in lung cancer]. Vopr Onkol (1978) 0.75
[Examination of pregnanediol in the urine by the method of thin layer chromatography on silica gel]. Lab Delo (1967) 0.75
[Diurnal urine sodium and potassium concentration in lung cancer patients]. Vopr Onkol (1970) 0.75
[Metabolic effect of tobacco smoke and "switching" the estrogen effect: mechanism of increased genotoxicity]. Vestn Ross Akad Med Nauk (2001) 0.75
[Estrogen-dependent peroxidase and hormone-dependent carcinogenesis]. Vopr Onkol (1999) 0.75
[Effect of glucose on fetal weight and the transplacental blastomogenic effect of N-nitrosomethylurea in rats]. Eksp Onkol (1985) 0.75
[Adenylate cyclase complex, lipids and the regulation of the hormonal sensitivity of tumor tissue]. Eksp Onkol (1986) 0.75
[Interrelationship between response to neoadjuvant hormone therapy and hormonal-metabolic status in breast cancer patients]. Vopr Onkol (2001) 0.75
[Carcinoembryonic antigen in the blood in the process of correcting carbohydrate metabolic disorders in patients with gastrointestinal cancer]. Med Radiol (Mosk) (1983) 0.75
[Effect of fenformin and miscleron on the delayed hypersensitivity reaction in breast cancer patients]. Vopr Onkol (1980) 0.75
[Size and number of adipocytes in the perirenal fatty tissue in pregnancy and in the postpartum period in rats]. Biull Eksp Biol Med (1977) 0.75
[Inhibition of the hypercalcemic effect of endogenous parathyroid hormone by its azo derivative in the EDTA test]. Vopr Med Khim (1972) 0.75
[Thyroxine depression of compensatory hypertrophy of the thyroid gland in rats of different ages]. Biull Eksp Biol Med (1975) 0.75
[75th anniversary of the publication of N. N. Petrov's manual "A General Theory of Tumors"]. Vopr Onkol (1985) 0.75
[Correlation of lymphocytic infiltration of tumor tissue with the hormonal and metabolic state in patients with breast cancer]. Vopr Onkol (1996) 0.75
[Gail's coefficient in breast cancer patients with respect to menstrual status, body mass and estrogen receptor pattern of tumor]. Vopr Onkol (2004) 0.75
[Antibodies to thyroglobulin in patients with cancer]. Vopr Onkol (1977) 0.75
[On the unification of the expression of results of determination of steroid hormones in urine]. Lab Delo (1969) 0.75
[Molecular-genetic aspects of estrogen production. Aromatase gene]. Mol Biol (Mosk) (1998) 0.75
[Inhibition of growth, fat-mobilization and lactogenic effects of somatotropic hormone with antiserum to anahormone of human placental lactogen]. Biull Eksp Biol Med (1972) 0.75
[Evolutionary oncoendocrinology]. Zh Evol Biokhim Fiziol (2001) 0.75
[Insulin-like growth factor-1, its binding protein (BP-3) and insulin in colorectal cancer]. Vopr Onkol (2001) 0.75
[Prostaglandins and their physiologic role]. Usp Fiziol Nauk (1976) 0.75
[Prognosis of breast cancer patients with large-fetus birth weights in their history]. Vopr Onkol (1981) 0.75
[Aromatase activity in human muscle tissue]. Vopr Med Khim (1997) 0.75
[Effect of phenformin (dibotin) on the state of fat-carbohydrate metabolism and fetal weight in pregnant rats previously given alloxan]. Patol Fiziol Eksp Ter (1977) 0.75
[Effect of hypolipidemic preparations on basal and stimulated adenylate cyclase activity in tumor cells]. Biull Eksp Biol Med (1985) 0.75
[Retrospective data on the weight of newborn infants in oncological patients]. Vopr Onkol (1973) 0.75
[Anahormone-chimeras. Hormonally-inactive conjugate of bovine ACTH and human somatotropin, retaining the antigenic properties of the original hormones]. Dokl Akad Nauk SSSR (1972) 0.75
[Effect of phenformin on fetal mass in rats previously immunized with an extract of homologous thyroid gland]. Biull Eksp Biol Med (1981) 0.75
[Cyclic nucleotides in clinical oncology]. Vopr Onkol (1982) 0.75
[Effect of neoadjuvant therapy with neovir on the level of steroid hormone receptors in endometrial cancer tissue]. Vopr Onkol (2001) 0.75
[Molecular biological and biochemical features of breast cancer]. Vestn Ross Akad Med Nauk (1998) 0.75
[Peroxidase activity in human uterine tissue: connection with clinico-morphological features of endometrial cancer]. Vopr Onkol (2001) 0.75
[Morphometric and biochemical peculiarities of fatty tissue in patients with cancer of the breast and lung]. Vopr Onkol (1983) 0.75
[Use of suppositories for rectal immunization]. Zh Mikrobiol Epidemiol Immunobiol (1981) 0.75
[Dynamics of urinary excretion of cyclic nucleotides in cancer patients during a long-term follow-up]. Vopr Onkol (1987) 0.75
[Effect of systemic and central triiodothyronine administration on compensatory hypertrophy of the thyroid gland in rats of different ages]. Fiziol Zh SSSR Im I M Sechenova (1980) 0.75
[Current trends in the biological therapy of malignant tumors]. Vopr Onkol (1996) 0.75
[Comparative study of subcutaneous, rectal and peroral immunization with hormonal and nonhormonal proteins]. Patol Fiziol Eksp Ter (1978) 0.75
[Estradiol-2-hydroxylase activity in tumors of the corpus uteri and breast: the effect of smoking]. Vopr Onkol (2000) 0.75
[Characteristics of the hormonal metabolic status of patients with colonic and rectal cancer]. Eksp Onkol (1988) 0.75
[Endocrine changes in cancer of the rectum and colon]. Vopr Onkol (1987) 0.75
[Cyclic adenosine monophosphate in the fatty tissue of breast and lung cancer patients]. Vopr Med Khim (1982) 0.75
[Cyclic adenosine monophosphate content in the lymphocytes of cancer patients]. Eksp Onkol (1985) 0.75
[Effect of human serum lipoproteins on various indices of thyroid function in rats]. Probl Endokrinol (Mosk) (1982) 0.75
[Effect of thyroxine, insulin and cholesterol on the amount of cyclic adenosine monophosphate in normal and oncornavirus infected cells]. Tsitologiia (1977) 0.75
[Some functional characteristics of the genital system preceding the development of breast tumors]. Akush Ginekol (Mosk) (1973) 0.75
[Conversion of androstenedione in the lymphocytes infiltrating the breast tumor tissue]. Biull Eksp Biol Med (1997) 0.75
[Penetration of 3H-cyclic adenosine-3',5'-monophosphate into different tissues of mice]. Biull Eksp Biol Med (1982) 0.75